Welcome to Scholar Publishing Group

International Journal of World Medicine, 2022, 3(2); doi: 10.38007/IJWM.2022.030203.

Dihuang Yinzi Treatment of Hepatorenal Yin Deficiency Type Apoplexy

Author(s)

Xi Liu and Haizhe Zhou

Corresponding Author:
Haizhe Zhou
Affiliation(s)

Shaanxi University of Chinese Medicine, Xianyang, China

Abstract

Rehmannia yinzi is Liu Hejian's name, indications for the stroke, is now more by later doctors for the treatment of cerebrovascular disease stroke, liver and kidney Yin deficiency type.This article discusses the history of apoplexy, the application of rehmannia glutinis in ancient and modern times and the experimental and clinical research.

Keywords

Rehmannia Decoction Zi Stroke Liver and Kidney Yin Deficiency Liu Hejian Pharmacological Study

Cite This Paper

Xi Liu and Haizhe Zhou. Dihuang Yinzi Treatment of Hepatorenal Yin Deficiency Type Apoplexy. International Journal of World Medicine (2022), Vol. 3, Issue 2: 22-28. https://doi.org/10.38007/IJWM.2022.030203.

References

[1] Liu Hailiang, Zhu Kai, Wang Zhonglin. Et al on etiology, pathogenesis and syndrome treatment of apoplexy. Journal of integrated traditional Chinese and western medicine cardio-cerebrovascular diseases,vol 18, no.20, 3370-3373,2020.

[2] Nie Liyuan, Bai Shuaidong, Zhang Shixia, et al. Modern research progress of rehmannia YinZi. Journal of shanxi university of Chinese medicine, vol 23,no01,pp.60-64,2020. 

[3] Gao Yang, XIE Yanming. Research progress of risk factors for recurrence of ischemic stroke in traditional Chinese and western medicine. World science and technology - modernization of traditional Chinese medicine,vol. 22,no02,pp.452-458,.2020.

[4] Zhang Xiulin, Hui Zhen, Wang Sulei, et al. Clinical study on the treatment of Parkinson's disease pain by adding and reducing rehmannia decoction zi. Shaanxi Traditional Chinese Medicine.,vol 42,no05,pp.620-624,.2010.

[5] Liya Li, Hao Liu, Chaoyun Wang, et al. Rehmannia YinZi on ischemia-reperfusion rats after inflammation inhibitory effect. Journal of traditional Chinese medicine new drug and clinical pharmacology, vol .32, 01, 23-28.2010.

[6] Zhang Xiufen, Wang Simeng, Bai Jianying,et al. Ancient literature classic square rehmannia YinZi fastidious. Chinese journal of experimental formulas of Chinese medicine, vol .26,no.14,pp.59-64.2020.

[7] Liu Weiqun, Wu Songying. Research situation of dihuang yinzi in treatment of miliaria miliaria. Chinese modern doctor,.vol .58,no.04,pp.189-192.2020.

[8] Chen Siqi, Li Jiaxin, Wu Xinyu, et al. Pharmacological research progress of rehmannia glutinosa. Chemical engineers, vol .11,no.04,pp.46-50.2019.

[9] Li Jiaxin, Chen Siqi, GE Pengling. Dogwood pharmacology research progress. Journal of liaoning university of traditional Chinese medicine, 2022, 24 (4) : 63-66. 

[10] Li Fuxiang, Xu Min, Wang Jian, et al. Pharmacology research status and prospect of c. deserticola. Journal of anhui agricultural science bulletin, vol .11,no.16,pp.92-93.2006.

[11] An Chunna, ZHANG Hongning, PU Xiaoping. Advances in neuropharmacology of cistanche. Chinese journal of pharmacy, vol.46,no.12,pp.887-890,.2011 .

[12] Liu Yan, SUN Hongxia. Journal of beihua university (natural science), vol.17,no.05,pp.607-610,.2016 .

[13] Liu Xiaoli, Liu Shengwei, Liao Yuan,et al. Study on network pharmacology of Dendrobiine against cerebral ischemia-reperfusion injury. Chin J Pharmacovigilance,vol.19,no.03,pp.252-255.,.2020 .

[14] Chen Caiying, Zhan Ruoting, Chen Weiwen. Pharmacological research progress in medicinal indianmulberry root. Journal of traditional Chinese medicine new drug and clinical pharmacology, ,vol.20,no.3,pp.291-293,.2021 . 

[15] Xu Jing, Yao Pengyu, Zhao Jiayou. Ye Tianshi using radix rehmanniae YinZi experience analysis. Journal of traditional Chinese medicine of zhejiang,vol.56,no.4,pp.235-237,.2021 .

[16] He Jianguo. Clinical observation of adding and subtracting dihuang yinzi in treatment of aphasia Yin deficiency syndrome after stroke. Guangming traditional Chinese medicine,vol.29,no.04,pp.734-735,.2014.

[17] Zhang S. The clinical effect of adding and reducing dihuang Yinzi in treatment of aphasia with liver and kidney Yin deficiency in stroke. Journal of Aerospace Medicine,vol.32.,no.03,pp.347-348, 2020.

[18] Wu Weilin. Rehmannia YinZi treatment kidney essence loss of stroke sequela of 24 cases of clinical analysis. Journal of Inner Mongolia traditional Chinese medicine, vol.29.,no.15,pp.45-46., 2010.

[19] Li Zhongtai. Dihuang Yinzi combined with acupuncture treatment of aphasia in 29 cases of stroke with deficiency of kidney essence. Shi Zhen Traditional Chinese Medicine and Traditional Chinese medicine,vol.32.,no.06,pp.529, 2005.

[20] Zhu Sixing, Gu Boding, Shang Li, Yan Shiyun, Chen Liyun. Research on the diagnosis and treatment of Ding Ganren stroke disease and medical case examples. Global Journal of Traditional Chinese Medicine. vol.15.,no.04, 529, 2020.